Skip to content
★ Sign in to follow
ソレイジア・ファーマ株式会社 logo

ソレイジア・ファーマ株式会社 Stock: price and insider trades · Japan

JP·Mcap JP¥7.1BHealth Care

No insider purchase over the last 90 days. The latest, by ノムラ インターナショナル ピーエルシー(NOMURA INTERNATIONAL PLC), was filed 22 Nov 2022.

ソレイジア・ファーマ株式会社: what insiders have been doing

This page follows insider dealings at ソレイジア・ファーマ株式会社 as filed with EDINET (Japan FSA), a company from the Health Care sector. In the past year (1 November 2025 to 1 November 2026), 3 filings came from 1 insider.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Across the 3,213 companies tracked on its exchange, the median is 3 filings; at 3 filings, this issuer sits right on that mark. Looking back to 2021, when coverage begins, insiders filed 59 purchases and 225 sales.

Over the last twelve months, not one insider purchase of ソレイジア・ファーマ株式会社 stock was filed. Typically, a trade is published a median of 4 days after it takes place. This delay matters because a trade only becomes useful information once it is public.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.

Insider Decl.
341
Thresholds
n/a
Buy Volume
€8M
59 ops. · all time
Sell Volume
€8M
225 ops. · all time

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 23,110 of 26,911 companies
25.8
score / 100
Value
14
Quality
38
FCF yld-15%
Earn yld-12%
EV/EBITDA·
ROE-66%
Gross mgn48%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

JP¥26
Analyst consensus
·
Income statement
RevenueJP¥429M
Gross profitJP¥207M48% margin
EBITDA-JP¥862M-201% margin
Net income-JP¥876M-232.0% margin
Valuation
P/Book4.9x
Beta1.18
Balance sheet & cash
Market capJP¥7.1B
Total debtJP¥16M
Free Cash Flow-JP¥1B
Debt / Equity5%
Profitability & ownership
ROE-66.0%
ROA-29.6%
% insiders14.6%
% institutions1.2%
Last declaration on 16 January 2026
Declarations341 total
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100XG60
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100XE5H
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100X742
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100WLLC
  • ●
    Related company / holdingExecutives
    6EDINET
    10.9% of flowShareXTKSEDINET:S100WGNE
  • ●
    Related company / holdingExecutives
    5EDINET
    4.0% of flowShareXTKSEDINET:S100WE08
  • ●
    Related company / holdingExecutives
    5EDINET
    2.6% of flowShareXTKSEDINET:S100WCEK
  • ●
    Related company / holdingExecutives
    6EDINET
    5.7% of flowShareXTKSEDINET:S100WC4D
  • ●
    Related company / holdingExecutives
    7EDINET
    16.9% of flowShareXTKSEDINET:S100WB28
  • ●
    Related company / holdingExecutives
    9EDINET
    36.7% of flowShareXTKSEDINET:S100WASA
  • ●
    Related company / holdingExecutives
    5EDINET
    0.4% of flowShareXTKSEDINET:S100W979
  • ●
    Related company / holdingExecutives
    6EDINET
    7.3% of flowShareXTKSEDINET:S100W28R
  • ●
    Related company / holdingExecutives
    5EDINET
    3.7% of flowShareXTKSEDINET:S100VYJB
  • ●
    Related company / holdingExecutives
    5EDINET
    1.5% of flowShareXTKSEDINET:S100VSN4
  • ●
    Related company / holdingExecutives
    11EDINET
    0.5% of flowShareXTKSEDINET:S100VSOE
  • ●
    Related company / holdingExecutives
    5EDINET
    0.5% of flowShareXTKSEDINET:S100VLXH
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100U3RX
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100U15J
  • ●
    Related company / holdingExecutives
    5EDINET
    0.7% of flowShareXTKSEDINET:S100U0M2
  • ▼
    Related company / holdingExecutives
    €169kest.0EDINET
    979,200 sharesShareXTKSEDINET:S100U0M2:T54
  • ▼
    Related company / holdingExecutives
    €1,729est.0EDINET
    10,600 sharesShareXTKSEDINET:S100U0M2:T48
  • ▼
    Related company / holdingExecutives
    €55kest.0EDINET
    320,800 sharesShareXTKSEDINET:S100U0M2:T51
  • ▼
    Related company / holdingExecutives
    €25kest.0EDINET
    146,700 sharesShareXTKSEDINET:S100U0M2:T55
  • ▼
    Related company / holdingExecutives
    €263kest.0EDINET
    1,527,700 sharesShareXTKSEDINET:S100U0M2:T58
  • ●
    Related company / holdingExecutives
    5EDINET
    0.4% of flowShareXTKSEDINET:S100TV6S

25 of 341 declarations

About ソレイジア・ファーマ株式会社

Solexia Pharma Co., Ltd. is a company focused on the health and pharmaceutical sector, dedicated to developing innovative treatments. It is listed on the XTKS market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations